ArticleMolecular and clinical oncology2024

Refractory insulin resistance and hemophagocytic lymphohistiocytosis following enfortumab vedotin treatment: A case report.

Pierre Rossignon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.